Times Private Treaties kicks off 2010 with Investment in Birla Life Sciences
03/18/2010

Times Private Treaties invests in Birla Lifesciences, a Yash Birla Group Company.

Online PR News – 18-March-2010 – – Times Private Treaties kicked off 2010 with investment in Birla Life Sciences, a Yash Birla Group Company. The deal is the first in 2010 for Times Private Treaties adding to its portfolio in the healthcare sector; which comprises of clients such as HCG Oncology, Thyrocare, Apollo Clinic, Richfeel and more.

Birla Lifesciences Pvt Ltd. is a newly incorporated entity under Birla Wellness. Birla Lifesciences aims to re-ignite faith in the ancient science of natural products, by combining modern technology with time tested wisdom to get highly efficacious and safe products. Birla Life Sciences is in the business of Ayurvedic medicines "Birlaveda", Natural Cosmetic Products "Chant", Health Foods "Nutrinext" and Wellness Services "Rebirth stores."

According to a latest report in the Express Pharma, the total market size of the Indian ayurvedic market is Rs 8000 crore and it is growing substantially between 10-15 percent, with the same growth rate targeted for the next 10 years.

Currently, more than 30,000 branded and 1,500 traditional ayurvedic products are available in the market. At present, India manufactures ayurvedic drugs worth Rs 6,000 crore per year, of which Rs 1,500 crore are exported. About 60 percent of this are crude herbs to be manufactured into products outside India, about 30 percent are finished product shipped abroad for direct sales to consumers, and the remaining 10 percent partially prepared products to be finished in foreign countries.

The Times Private Treaties innovative model is based on providing brand building and advertising opportunities to help companies create their brand and unlock value. This model enables companies to advertise in BCCL vehicles. This also helps the company to bring in many first time advertisers to BCCL’s advertiser base.